Get the Weekly Intelligence Brief — top committee picks every Sunday.

ALC vs TEVA

Alcon Inc vs Teva Pharmaceutical Industries Limited — AI-powered side-by-side comparison
ALC
Alcon Inc
68
Buy
VS
TEVA
Teva Pharmaceutical Industries Limited
55
Watch
MetricALCTEVA
AI Score 68 55
Price $75.39 $36.49
P/E Ratio 45.39× 57.19×
ROE 4.4% 17.8%
Revenue Growth YoY
Gross Margin 54.9% 52.5%
Debt / Equity 0.24× 2.16×
Dividend Yield 0.5% 0.0%
RSI (14) 73.4 77.8
Beta 0.703 0.864
Expected Upside +11.3%

AI Committee View

Current Innellis committee reasoning for ALC versus TEVA.
ALC leads by 13 points.

ALC scores 68/100 (Buy) versus TEVA at 55/100 (Watch).

ALC Committee View
75% agreement
4 analysts

The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. The main limiting factor is rsi at 73 is in overbought territory. The committee is constructive but not yet at full conviction.

Bull Case
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • MACD histogram positive -- bullish momentum — Technical
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
  • RSI at 73 is in overbought territory — Technical
  • Price trading above the upper Bollinger Band -- stretched — Technical
TEVA Committee View
50% agreement
6 analysts

The committee is genuinely divided. News Analyst sees a compelling case — news sentiment is positive (+0.63 across 21 articles, 14d). Value Analyst remains cautious — p/e of 57.5 is expensive by classic value standards. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
  • Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
  • P/E of 57.5 is expensive by classic value standards — Value
  • Price-to-book of 4.9x prices in significant intangible value — Value
  • Debt-to-equity of 2.12 adds balance-sheet risk to the value case — Value
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
ALC Full Analysis TEVA Full Analysis